Weakness after Capromorelin (Entyce) in dogs

101 reports to the FDA describe weakness in dogs given Capromorelin. That is 6.7% of all reports for this medicine, compared with 1.4% across reports for all dog medicines, so it is reported unusually often with this medicine.

101Reports

81%Marked serious

17%Recovered

48%Died or euthanised

7 daysTypical onset

How soon it started

Same day

22 26%

1–2 days

14 17%

3–7 days

7 8.3%

1–4 weeks

18 21%

Over a month

23 27%

How the animals did

Recovered

16 16%

Recovered with lasting effects

1 1.0%

Still unwell when reported

22 22%

Died

17 17%

Euthanised

31 31%

Not known

14 14%

Problems reported at the same time

52 51%

48 48%

46 46%

34 34%

33 33%

31 31%

28 28%

23 23%

Age of the animals

Under 1 year

1–3 years

4–7 years

8–11 years

12+ years

About this medicine

Capromorelin stimulates appetite.

Products with this ingredient include Entyce, Elura. The FDA hides brand names in its public data, so these reports cover every product with the same active ingredients.

Questions owners ask

Can Capromorelin cause weakness in dogs?: 101 reports link the two, but a report alone does not prove the medicine was the cause: other illnesses, other medicines or coincidence can be involved. Your vet can judge it for your animal.
How soon after a dose was it reported?: In half of the reports with dates, it started within 7 days of the first dose.
What should I do?: Don't give another dose until you've spoken to your vet, and keep the packaging so you can tell them the product and dose. Your vet can also report it to the FDA (or you can, through the manufacturer or FDA form 1932a).

Weakness with similar medicines

Weakness after Maropitant (Cerenia) 618 reports · 5.2% of its reports

All reported side effects of Capromorelin in dogs · Medicines most reported with weakness